How Do Hospitals Get Their Patients Back?

Facing previously unforeseen shortages of personal protective equipment and supplies, provider systems like the Mayo Clinic enlisted engineering departments to help fill the materials gap with 3D printing and other approaches. With the surge in the rearview mirror, those hospital systems now are turning to those same teams to get their facilities ready for the return of patients. In this discussion, a panel of engineering and health professionals share how the venerable institution is moving to reopen in a safe and thoughtful manner.

Panelists:

• Sean McEligot, Section Head Technology Development, Mayo Clinic, Division of Engineering
• Amy Alexander, Senior Biomedical Engineer, Mayo Clinical Anatomical Modeling Lab
• Jonathan Morris, Consultant, Diagnostic Radiology, Director of Mayo Anatomical Modeling Lab

Moderator:

• Mark Wehde, Chair, Mayo Clinic Division of Engineering

Who Should Attend: Product Developers, Project Managers, Manufacturers, Providers, Business Development Managers, Sales Executives, Payer Representatives

Maculogix/MPR: Putting innovative diagnostics into a smaller, sleeker, wearable device

MacuLogix CTO and co-founder Gregory Jackson jokes that he fainted when CEO Bill McPhee decided the company had to create an AI-enabled and wearable version of its revolutionary AdaptDx device used to diagnose macular degeneration. But the development of AdaptDx Pro went smoothly when Maculogix found the right partners like MPR Associates. In this discussion, Jackson and two principals from MPR – Jeff Champagne and Craig Mauch – will walk through the process that put the functionality of a benchtop system into a sleek, wearable device.

Panelists:

• Jeffrey Champagne, Director of Business Development Product Development Group, MPR
• Gregory Jackson, PhD, CTO and Co-Founder, MacuLogix
• Craig Mauch, Director, Product Design, MPR

Who Should Attend: Product Developers, Project Managers, Design Professionals, Manufacturers, Business Development Managers

How skin-interfaced, medical-grade wearables will allow devices to continuously track physiological status

Professor Rogers will lay out his lab’s ongoing development of skin-interfaced, wireless wearables capable of ICU-grade monitoring, both in the clinic and the home. These advanced tools also support simultaneous capabilities in continuous tracking of novel metrics of patient health, with the ability to provide comprehensive, and potentially predictive, assessments of physiological status using advanced data analytics approaches.

Panelist:

• Prof. John A. Rogers, Louis Simpson and Kimberly Querry Professor of Materials Science and Engineering, Biomedical Engineering, and Neurological Surgery, Northwestern University

Who Should Attend: Product Developers, Project Managers, Manufacturers, Providers, Provider Executives, Business Development Managers, Start-up executives, entrepreneurs

Where is the medtech job market headed?

The impact of COVID-19 hit medtech’s bottom line hard forcing companies to scale back on payroll through layoffs and salary cuts. But the sector will recover as hospitals learn to manage patient care in a pandemic. What can companies and medtech professionals do to ensure they’ve got the best team in place to succeed?

Panelists:

• David L. Vied, Global Sector Leader for the Medical Devices and Diagnostics, Korn Ferry
• Giovanni Lauricella, Vice President, Medtech Practice-Lead, The Mullings Group
• Molly Robb, Managing Director, BioQuest

Who Should Attend: Investors, Start-up executives, Technology professionals, Product Developers, Project Managers, Manufacturers, Providers, Business Development Managers, Sales Executives

How COVID-19 is creating new IP and litigation challenges for medtechs

The medtech industry is being pressed to meet the many challenges presented by the pandemic. While medtech’s help is needed to create new tools and tests, the pandemic presents unprecedented challenges and opportunities for the industry.

In this discussion, our panel of experienced trial lawyers and IP counsel will discuss the following important and timely developments and trends:

• IP strategy for companies innovating new technology or forming new collaborations
• Liability risks and immunity protections
• Impact of COVID-19 on litigation in the medtech industry

Panelists:

• David Dykeman, Co-Chair, Global Life Sciences & Medical Technology Group Patent Attorney & Co-Managing Shareholder, Greenberg Traurig Boston
• Ginger Pigott, Vice Chair, Pharmaceutical, Medical Device & Health Care Litigation Practice, Greenberg Traurig LA
• Libretta Stennes, Shareholder, Greenberg Traurig Minneapolis

Who Should Attend: Entrepreneurs, Investors, Product Developers, Project Managers, Design Professionals, Manufacturers, Business Development Managers